M

    Moleculin Biotech Inc (MBRX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.64
    -0.01 (-0.80%)

    Market Cap: $12.66M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    51%(19/37)
    Avg Surprise
    +7.60%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.44
    Range$-0.54 - $-0.34
    2 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$-1.07-143.2%
    60d ago$-1.07-143.2%
    30d ago$-1.01-130.7%
    7d ago$-0.87-97.7%
    Current$-0.44
    Revenue Consensus
    $0
    Range$0 - $0
    3 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.42
    Range$0.13 - $0.72
    2 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.42---
    Sep 26EST
    		-$-0.44---
    Jun 26
    Reported Aug 11
    		$-1.40$-1.55+9.68%Beat+88.6%
    Mar 26
    Reported May 14
    		$-3.54$-1.66-113.25%Miss+79.5%
    Dec 25
    Reported Mar 20
    		$4.83$-6.11+178.99%Beat+966.9%
    Sep 25
    Reported Nov 13
    		$-0.68N/A+89.67%Beat+99.0%
    Jun 25
    Reported Aug 12
    		$-12.25$-10.08-21.53%Miss+71.2%
    Mar 25
    Reported May 13
    		$-17.25$-13.87-24.37%Miss+65.8%
    Dec 24
    Reported Mar 21
    		$-0.56N/A+56.60%Beat+88.9%
    Sep 24
    Reported Nov 11
    		$-71.25$-61.00-16.80%Miss+0.0%
    Jun 24
    Reported Aug 13
    		$-42.50$-62.75+32.27%Beat+44.0%
    Mar 24
    Reported May 10
    		$-50.50$-88.25+42.78%Beat+51.3%
    Dec 23
    Reported Mar 22
    		$-5.02$-3.05-64.59%Miss-2082.6%
    Sep 23
    Reported Nov 13
    		$-71.25$-75.00+5.00%Beat+36.7%
    Jun 23
    Reported Aug 11
    		$-75.94$-99.37+23.58%Beat+21.6%
    Mar 23
    Reported May 11
    		$-103.76$-114.37+9.28%Beat-15.3%
    Dec 22
    Reported Mar 22
    		$-0.23$-0.30+23.33%Beat-155.6%
    Sep 22
    Reported Nov 10
    		$-112.50$-103.75-8.43%Miss-41.5%
    Jun 22
    Reported Aug 15
    		$-96.82$-95.62-1.25%Miss-35.6%
    Mar 22
    Reported May 11
    		$-90.00$-78.75-14.29%Miss-20.0%
    Dec 21
    Reported Mar 25
    		$-0.09N/A+57.14%Beat+65.4%
    Sep 21
    Reported Nov 11
    		$-79.50$-77.50-2.58%Miss+64.6%
    Jun 21
    Reported Aug 12
    		$-71.40$-70.00-2.00%Miss+62.3%
    Mar 21
    Reported May 12
    		$-75.00$-86.25+13.04%Beat+67.1%
    Dec 20
    Reported Mar 24
    		$-0.26N/A+55.17%Beat+45.8%
    Sep 20
    Reported Nov 13
    		$-224.66$-210.00-6.98%Miss-6.4%
    Jun 20
    Reported Aug 12
    		$-189.63$-202.50+6.36%Beat+1.5%
    Mar 20
    Reported May 11
    		$-227.70$-225.00-1.20%Miss+27.7%
    Dec 19
    Reported Mar 19
    		$-0.48$-0.66+27.27%Beat+99.8%
    Sep 19
    Reported Nov 12
    		$-211.05$-195.00-8.23%Miss-17.3%
    Jun 19
    Reported Aug 16
    		$-192.60$-270.00+28.67%Beat+57.2%
    Mar 19
    Reported May 13
    		$-315.00$-202.50-55.56%Miss-23.9%
    Dec 18
    Reported Feb 21
    		$-225.00$-225.00+0.00%Beat-23337.5%
    Sep 18
    Reported Nov 13
    		$-180.00$-292.50+38.46%Beat-128471.4%
    Jun 18
    Reported Aug 13
    		$-450.00$-315.00-42.86%Miss-236742.1%
    Mar 18
    Reported May 15
    		$-254.25$-315.00+19.29%Beat-35212.5%
    Dec 17
    Reported Mar 28
    		$-0.96$-0.72-33.33%Miss-700.0%
    Sep 17
    Reported Nov 14
    		$-0.14N/AN/ABeat-
    Jun 17
    Reported Aug 14
    		$-0.19$0.00N/ABeat-
    Mar 17
    Reported Apr 3
    		$-0.72$-0.66-9.09%Miss-
    Sep 16
    Reported Nov 21
    		$-0.12$-0.11-9.09%Miss-

    Key Metrics

    Valuation
    P/E Ratio-0.81EV/EBITDA0.52x
    Price/FCF-0.14xFCF Yield-692.37%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-1372.00%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio0.94xQuick Ratio0.94x
    Trading Statistics
    Beta1.83Avg Volume1.44M
    52-Week High$15.7552-Week Low$0.16

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.62
    SMA 20$0.55
    SMA 50$1.57
    SMA 200$3.24
    EMA 10$0.63
    EMA 20$0.75
    EMA 50$1.31
    EMA 200$4.49

    MACD

    Line: -0.23Signal: -0.31Hist: 0.08

    ADX

    ADX: 40.2+DI: 18.1-DI: 33.2

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down20.0
    PSAR$0.50

    Bollinger Bands

    Upper Band$0.74
    Lower Band$0.35
    %B Position7138%(Upper)
    Band Width0.75

    RSI (14-Day)

    Neutral
    34.2

    Momentum Oscillators

    Stoch %K82.8
    Stoch %D83.0
    Williams %R-23.8
    ROC (10d)6.2%
    Momentum0.04
    CCI (20d)77.1
    MFI (14d)74.8

    Volatility Measures

    ATR (14d)$0.12(18.0%)
    StdDev (20d)0.10
    Hist Vol100.7%(High)

    Volume Flow

    VWAP$0.65
    OBV129.8M
    AD Line233.8B
    CMF (20d)0.031

    Volume Metrics

    Avg Vol (20d)1.1M
    Vol Ratio0.3x(Low)
    VWMA (20d)$0.52

    Pivot Points

    R3$0.76
    R2$0.74
    R1$0.69
    Pivot Point$0.67
    S1$0.62
    S2$0.60
    S3$0.55

    Advanced Oscillators

    TSI-42.37
    Ultimate Osc44.1
    KST-347.92

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$126,000$0$0$0$406,000$0
    Cost of Revenue$0$0$9,000$0$0$0$31,000$0$0$0$35,000$0
    Gross Profit$0$0$-9,000$0$0$0$-31,000$0$0$0$-35,000$0
    Operating Expenses$7.56M$7.87M$7.53M$5.91M$5.72M$5.94M$6.64M$7.13M$6.18M$6.68M$8.92M$5.95M
    R&D$5.45M$5.38M$5.12M$3.74M$3.60M$3.44M$4.46M$4.93M$4.09M$4.25M$6.63M$3.28M
    SG&A$2.10M$2.49M$2.41M$2.15M$2.09M$2.48M$2.16M$2.17M$2.06M$2.39M$2.25M$2.63M
    Operating Income$-7,561,000$-7,874,000$-7,534,000$-5,906,000$-5,720,000$-5,943,000$-6,644,000$-7,135,000$-6,185,000$-6,677,000$-8,919,000$-5,947,000
    Interest Income$-78,000$34,000$10,000$39,000$26,000$30,000$48,000$102,000$159,000$241,000$262,000$324,000
    Interest Expense$87,000$5.05M$0$19.51M$12.09M$0$3.10M$0$0$0$1.37M$0
    Income Before Tax$-7,648,000$-12,921,000$5.96M$-25,415,000$-17,813,000$-5,913,000$-9,747,000$-7,033,000$-4,330,000$-4,981,000$-10,287,000$-5,622,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-7,635,000$-12,845,000$5.92M$-25,399,000$-17,809,000$-5,904,000$-9,735,000$-7,024,000$-4,319,000$-4,970,000$-10,269,000$-5,609,000
    EBITDA$-7,562,000$-12,947,000$5.96M$-25,432,000$-17,811,000$-5,912,000$-9,764,000$-7,103,000$-4,458,000$-5,190,000$-10,514,000$-5,915,000
    EBIT$-7,570,000$-12,955,000$5.95M$-25,454,000$-17,839,000$-5,943,000$-9,795,000$-7,135,000$-4,489,000$-5,222,000$-10,549,000$-5,946,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MBRX

    News

    Signal Proxy Intelligence Recommends AGAINST Moleculin Biotech, Inc. Executive Compensation Ahead of Oct. 9, 2026 Annual Meeting (NASDAQ:MBRX)

    Signal Proxy Intelligence recommends against Moleculin Biotech, Inc.'s executive compensation plan for its upcoming October 9, 2026 annual meeting, citing low shareholder support for executive pay in 2025. The independent research firm also provided recommendations for six other ballot measures, including supporting director nominees and an amendment to increase shares authorized for its equity incentive plan. The full analysis is available on Signal Law Group's website.

    WAOW•8/27/26•
    Somewhat-Bearish

    Moleculin (MBRX) CFO put $220K into stock—how big a stake did he build?

    Moleculin Biotech's CFO, Jonathan P. Foster, has reported beneficial ownership of 1,288,207 shares, or 6.3% of the company's outstanding common stock, after investing approximately $220,000 in a recent public offering. This significant stake includes direct shares, Series I warrants, and other exercisable options. The filing indicates his investment is for general purposes, though Foster, as CFO, participates in corporate activities including proposals for director elections and a potential reverse stock split.

    Stock Titan•8/25/26•
    Somewhat-Bullish

    Moleculin (NASDAQ: MBRX) CEO invests $400K of own cash

    Moleculin Biotech, Inc.'s CEO, Walter V. Klemp, has significantly increased his stake in the company by investing approximately $400,000 of personal funds in a public offering. This acquisition, made through common stock and Series I warrants, brings his beneficial ownership to 9.87% of the outstanding shares, inclusive of holdings through AnnaMed, Inc., which he controls. The investment reinforces Klemp's commitment to the company, aligning with recent proposals for corporate governance changes and the continued advancement of Moleculin's clinical trials.

    Stock Titan•8/25/26•
    Somewhat-Bullish

    Walter V. Klemp Discloses Investment at Moleculin Biotech with 9.87% Stake

    Walter V. Klemp, Chairman, CEO, and President of Moleculin Biotech, Inc., has disclosed a 9.87% stake in the company's common stock, following purchases in an August 3, 2026 public offering. This move, documented in a Schedule 13D filing on August 25, 2026, signifies insider buying and includes warrants that limit his ownership unless he elects a higher cap, which he has done to 9.99% as of October 18, 2026. Klemp's investment aligns with his history of supporting life sciences ventures and Moleculin’s oncology programs.

    TradingView•8/25/26•
    Bullish

    Price to book forward of Moleculin Biotech, Inc. – NASDAQ:MBRX

    This article provides a financial data point for Moleculin Biotech, Inc. (NASDAQ: MBRX), specifically its "Price to book forward" metric. The content itself is very minimal, presenting only the company name, stock ticker, and the financial metric within the context of a trading platform interface.

    TradingView•8/25/26•
    Neutral

    Frequently Asked Questions About MBRX

    Does MBRX pay dividends?
    Moleculin Biotech Inc (MBRX) does not currently pay a regular dividend.
    What is MBRX's market cap?
    Moleculin Biotech Inc (MBRX) has a market capitalization of $12.66M with a current stock price of $0.64.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In